Improving the outcome for patients after osteoporotic femoral fractures - Improving the outcome for patients after osteoporotic femoral fracture

Phase 1

• Conditions: OSTEOPOROTIC FEMORAL FRACTURE

• Registration Number: EUCTR2009-015058-38-GB
• Lead Sponsor: niversity of Leeds

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-08-17
• Last Update Posted: 28 February 2019

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

- Patients with acute traumatic trochanteric or supracondylar femoral fractures and fragility fractures (i.e. sustained from standing height or less and radiological features of osteoporosis). - Patients who are aged 55 or older.
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 0
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

- Patients with open fractures, pathological fractures, ‘floating knee’, associated patellar fractures or simultaneous bilateral fractures - Patients with a known metabolic bone disease, rheumatoid arthritis or chronic renal failure - Patients with dementia - Patients with bone metastases or other malignant bone disease - Patients taking steroids, strontium, biphosphonates or PTH -Patients with oesophageal abnormalities, swallowing problems, hypocalcaemia, hypercalcemia. - Women of child-bearing age (<55years), pregnant or breast feeding.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified